Skip to content
Screener

Lineage Cell Therapeutics LCTX Q2 2025 earnings

Reported August 12, 2025 · After market close

Revenue$2.8MBeat by $876.1K
EPS-$0.01Beat by $0.01
Revenue estimate$1.9M
EPS estimate-$0.02

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$1.3M
EPS estimate-$0.03

FAQ

When did Lineage Cell Therapeutics report Q2 2025 earnings?
Lineage Cell Therapeutics (LCTX) reported Q2 2025 earnings on August 12, 2025 after market close.
What were Lineage Cell Therapeutics's Q2 2025 revenue and EPS?
Lineage Cell Therapeutics reported revenue of $2.8M and eps of $-0.01 for Q2 2025.
Did Lineage Cell Therapeutics beat estimates in Q2 2025?
Revenue beat the consensus estimate of $1.9M by $876.1K. EPS beat the consensus estimate of $-0.02 by $0.01.
How did Lineage Cell Therapeutics's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 96.4% from $1.4M a year earlier and eps grew 66.7% from $-0.03.
Where can I find Lineage Cell Therapeutics's Q2 2025 SEC filings?
You can read the 8-K earnings release (0000950170-25-107314) and the 10-Q periodic report (0000950170-25-107333) directly on SEC EDGAR. The filing index links above go to sec.gov.